Access cutting-edge invasive fungal infection treatment through this clinical trial at a research site in Durham. Study-provided care at no cost to qualified participants.
Access invasive fungal infection specialists in Durham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related invasive fungal infection treatment provided free
This study aims to estimate the pharmacokinetics (PK) of posaconazole (POS, MK-5592) intravenous (IV) and powder for oral suspension (PFS) formulations in pediatric participants \<2 years of age with invasive fungal infection (IFI).
Sponsor: Merck Sharp & Dohme LLC
Check if you qualify for this invasive fungal infection clinical trial in Durham, NC
If you're searching for invasive fungal infection treatment options in Durham, NC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Durham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced invasive fungal infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.